And then with SOTYKTU readouts in 2026. Two studies in SLE followed by a readout in '27 with Sjogren's syndrome. It's a really exciting time. These are just studies in the areas of immunology ...

Just a few weeks after its approval in the UK, Bristol-Myers Squibb’s new oral psoriasis therapy Sotyktu has been recommended for routine NHS in England and Wales. The National Institute for ...

Deucravacitinib (Sotyktu) demonstrated efficacy in treating patients with active psoriatic arthritis (PsA), achieving higher American College of Rheumatology (ACR) 20 response rates (ie ...

Rosie O’Donnell has left the United States and moved to Ireland in early January and will not return until it’s “safe for all citizens to have equal rights,” the actress and comedian ...

Specifically, results from the phase 3 ICONIC-ADVANCE 1 & 2 studies not only showed icotrokinra to achieve the intended evaluable co-primary endpoints, but to also attain superiority over SOTYKTU ...

2025--Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared... PRINCETON, N.J., March 07, 2025--Bristol ...

If approved, it will compete with Bristol-Myers Squibb's TYK2 inhibitor Sotyktu (deucravacitinib), which has seen impressive sales growth since launch, thanks to its oral dosing and efficacy that ...

Sakshi marks her debut as an actress in the Telugu film "Agent" in 2023, sharing the screen with well-known actors Akhil Akkineni and Mammootty.Personal DetailsSakshi Vaidya was born on May 19 ...